EHAB logo

Enhabit Inc. (EHAB)

$13.60

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on EHAB

Market cap

$688256220

EPS

-0.25

P/E ratio

--

Price to sales

0.54

Dividend yield

--

Beta

1.274997

Price on EHAB

Previous close

$11.09

Today's open

$13.58

Day's range

$13.55 - $13.64

52 week range

$6.47 - $13.64

Profile about EHAB

CEO

Barbara A. Jacobsmeyer

Employees

10700

Headquarters

Dallas, TX

Exchange

New York Stock Exchange

Shares outstanding

50607075

Issue type

Common Stock

EHAB industries and sectors

Healthcare

Healthcare Providers & Services

News on EHAB

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Enhabit Inc. (NYSE: EHAB)

NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Enhabit Inc. (NYSE: EHAB) related to its sale to Kinderhook Industries, LLC.

news source

PRNewsWire • 7 hours ago

news preview

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Enhabit, Inc. (EHAB)

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - February 24, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Enhabit, Inc. ("Enhabit" or the "Company") (NYSE: EHAB) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Kinderhook Industries, LLC ("Kinderhook") for $13.80 a share in an all-cash transaction for a total enterprise value of approximately $1.1 billion. The investigation concerns whether the Enhabit Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

news source

Newsfile Corp • 10 hours ago

news preview

Enhabit (EHAB) Surges 22.6%: Is This an Indication of Further Gains?

Enhabit (EHAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

news source

Zacks Investment Research • 10 hours ago

news preview

Enhabit to be Acquired by Kinderhook Industries

DALLAS & NEW YORK--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC (“Kinderhook”), a middle market private equity firm, in an all-cash transaction for a total enterprise value of approximately $1.1 billion. Under the terms of the agreement, Enhabit stockholders will receive $13.80 per share in cash, which represents a premium of approximately.

news source

Business Wire • Feb 23, 2026

news preview

Shareholder Alert: The Ademi Firm investigates whether Enhabit Inc. is obtaining a Fair Price for its Public Shareholders

MILWAUKEE, Feb. 23, 2026 /PRNewswire/ -- Ademi LLP is investigating Enhabit (NYSE: EHAB) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Kinderhook Industries. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.

news source

PRNewsWire • Feb 23, 2026

news preview

EHAB Stock Alert: Halper Sadeh LLC is Investigating Whether Enhabit, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, LLC for $13.80 per share in cash. Halper Sadeh encourages Enhabit shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether Enhabit and its board of directors violate.

news source

Business Wire • Feb 23, 2026

news preview

Enhabit Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enhabit, Inc. - EHAB

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enhabit, Inc. (NYSE: EHAB) to Kinderhook Industries, LLC. Under the terms of the proposed transaction, shareholders of Enhabit will receive $13.80 per share in cash. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration under.

news source

Business Wire • Feb 24, 2026

news preview

Enhabit Home Health & Hospice Announces Date of 2025 Fourth Quarter Earnings Call

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its financial results for the fourth quarter and fiscal year ended Dec. 31, 2025, on March 4, 2026, and host a webcast and conference call on March 5, 2026. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 5, 2026 9 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843.

news source

Business Wire • Feb 12, 2026

news preview

Despite Fast-paced Momentum, Enhabit (EHAB) Is Still a Bargain Stock

Enhabit (EHAB) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

news source

Zacks Investment Research • Feb 12, 2026

news preview

Enhabit and Encompass Health Collect $43.1 Million from Individual Defendants in Delaware Fiduciary Breach Case

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) announced today that, along with Encompass Health Corporation (NYSE: EHC), they have collected $43.1 million in full satisfaction of their claims for attorneys' fees and mitigation damages in the Delaware Court of Chancery against former officer Chris Walker, Vistria Group senior partner David Schuppan, and Nautic Partners managing director Christopher Corey. These claims related to the December 2024 judgment in favor of Enhabit and Encompass.

news source

Business Wire • Feb 12, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Enhabit Inc.

Open an M1 investment account to buy and sell Enhabit Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in EHAB on M1